REGENEREX PHARMA, INC. Deferred Tax Assets, Net of Valuation Allowance

REGENEREX PHARMA, INC. Deferred Tax Assets, Net of Valuation Allowance

REGENEREX PHARMA, INC. had Deferred Tax Assets, Net of Valuation Allowance of $0 as of 2025-12-31, per its 10-KT filed 2026-08-31.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsNet · last filed 2026-08-31

• 2025-12-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.
• 2025-03-31: Deferred Tax Assets, Net of Valuation Allowance $0.00.